Evidence map›Paper›PMID 41424314›Full record

ReviewJournal of internal medicine2026

The dysregulation of innate immunity by Porphyromonas gingivalis in the etiology of Alzheimer's disease.

Annelise E Barron, Jennifer S Lin, Mark I Ryder, Peter Bergman

Abstract readReview
In one paragraph

Review in Journal of internal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Annelise E BarronDepartment of Bioengineering, Schools of Medicine and of Engineering, Stanford University, Stanford, California, USA.
Jennifer S LinDepartment of Bioengineering, Schools of Medicine and of Engineering, Stanford University, Stanford, California, USA.ORCID https://orcid.org/0000-0001-9169-7410
Mark I RyderDepartment of Bioengineering, Schools of Medicine and of Engineering, Stanford University, Stanford, California, USA.ORCID https://orcid.org/0000-0002-8540-4017
Peter BergmanDepartment of Laboratory Medicine, Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-3306-3713

Funding

Role of Innate Immune Dysregulation in the Etiology of DementiaDP1AG072438 · NIA · STANFORD UNIVERSITY · PI BARRON, ANNELISE EMILY · 2020 to 2024
$5.2M
Cisco University Research Program FundNIA NIH HHS DP1 AG072438NIH HHS 1DP1OD029517SENS Research FoundationStanford University's Discovery Innovation FundTruchard Foundation
6 · The paper itself

Abstract

The etiology of Alzheimer's disease (AD) remains under active debate. In this perspective, we explore the hypothesis that a primarily infection-caused chronic dysregulation and weakening of human innate immunity via the underexpression, degradation, and inactivation of innate immune proteins necessary for direct antimicrobial effects and regulation of host defense and autophagy could lead to AD. Key evidence relates to the fact that important innate immune proteins such as LL-37-which can bind Aβ and block amyloid formation-as well as Apolipoprotein E, antiviral interferons, and TNF-α can be degraded and deactivated by enzymes produced by the common oral anaerobic pathogen Porphyromonas gingivalis (Pg). Pg produces numerous virulence factors; of particular importance for AD are Pg's gingipain cysteine proteases. Deleterious effects of chronic Pg infection and gingipains include a systemic downregulation and paralysis of the interferon response, particularly the antiviral interferon-lambda response, which enables replication of endemic herpesviruses. The result is a chronic, low-level viral infectious assault on gut, nerves, and brain causing the production of Aβ antimicrobial peptides, accumulation of Aβ plaques, phosphorylation of Tau, progressive neuroinflammation, and neurodegeneration. The resultant innate immune system dysregulation, as an AD etiology, ties together the well-known amyloid cascade hypothesis and the infectious theory of AD into a unified explanation of the pathology and cause of AD. If this theory holds true, it suggests preventative approaches: (1) test for and eradicate Pg from oral flora, and/or directly deactivate the gingipains; and (2) reduce Herpesvirus exacerbations by the use of antiviral drugs and/or vaccines (e.g., Bacillus Calmette-Guérin).

Indexed as

Alzheimer DiseaseBacteroidaceae InfectionsImmunity, InnatePorphyromonas gingivalisAmyloid beta-PeptidesCathelicidinsGingipain Cysteine EndopeptidasesHumansAmyloid beta-PeptidesCathelicidinsGingipain Cysteine Endopeptidasesantimicrobial peptidescathelicidinherpesviruseshost defense peptidesHSV‐1human cytomegalovirus (HCMV)LL‐37Porphyromonas gingivalis

Identifiers

PMID41424314
PMCPMC12869014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.